TGFβ could also sensitize non-small cell lung carcinomas to the broad-acting tyrosine kinase inhibitor dasatinib through upregulation of Bim and downregulation of Smad7 [558]. The gene discussed is BCL2L11; the disease is non-small cell lung carcinoma.